Source: smart ring maker Oura filed confidentially for a US IPO, set for later in 2026; SF- and Finland-based Oura had an $11B valuation in September 2025
Oura Health Oy, a maker of popular smart rings that track health, fitness and sleep, filed confidentially for a US initial public offering …
Context & Ripple Effects
Oura’s reported IPO filing follows a sharp private-market revaluation: related coverage placed its Series E valuation near $10.9B in September 2025, versus roughly $5B in November 2024. Earlier coverage traced the company’s expansion from sleep and health tracking into a broader health-focused wearable position.
The filing also follows reports that Oura considered a discounted tender offer for early investors to remain private longer. Moving toward a US listing instead would test whether public investors support the valuation established in its late-stage private financing.
First-order effects
- A confidential filing starts the IPO process for Oura while allowing it to refine timing and disclosure before a public launch later in 2026.
- Oura’s investors and employees gain a prospective public-market liquidity path after the previously reported plan for a discounted private tender offer.
Second-order effects
- A public offering would create a visible valuation benchmark for smart-ring and health-tracking peers; related coverage specifically identifies Whoop as another company reportedly considering an IPO.
- The planned listing raises the stakes for Oura to demonstrate that its health-focused positioning and newer, higher-priced Ring 5 can sustain growth and margins under public-market scrutiny.
Third-order effects
- If Oura and similar companies reach public markets at strong valuations, smart rings could become a more established standalone wearable category rather than an accessory segment defined chiefly by larger device makers.
- The contrast between a discounted private liquidity option and an IPO path underscores how late-stage wearable companies may increasingly use public-market readiness to reset expectations between private valuations and investor demand.
The trend: Health-oriented wearable companies are moving from venture-backed product growth toward public-market tests of whether specialized devices can support durable, independent platforms.